Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2
eBook - ePub

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2

Diagnosis, Therapeutic Targets, and Molecular Mechanisms

  1. 398 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2

Diagnosis, Therapeutic Targets, and Molecular Mechanisms

About this book

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume Two: Diagnosis, Therapeutic Targets and Molecular Mechanisms for Hepatocellular Carcinoma Progression provides comprehensive information about ongoing research and clinical data surrounding liver cancer. The book presents detailed descriptions about diagnostics and therapeutic options for easy understanding, with a focus on precision medicine approaches to improve treatment outcomes. The volume discusses topics such as computational approaches for identification of biomarkers, enzymes and pathways of HCC, circulating and epigenetic biomarkers, drug resistance, metabolic pathways, and small molecule-target therapies. In addition, it discusses immunotherapies, immune check point inhibitors and nanotechnology-based therapies. This book is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting. - Provides detailed information on traditional and novel diagnostic tools for hepatocellular carcinoma - Discusses promising targeted therapies, both available and in development, explaining the best option to use for specific cases - Brings recent findings in immunotherapies, immune checkpoint inhibitors and nanotechnology-based therapeutic approaches for treatment of HCC

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2 by Ganji Purnachandra Nagaraju,Ramakrishna Vadde in PDF and/or ePUB format, as well as other popular books in Psychology & Cognitive Neuroscience & Neuropsychology. We have over one million books available in our catalogue for you to explore.

Table of contents

  1. Cover
  2. Title page
  3. Table of Contents
  4. Copyright
  5. Dedication
  6. Contents
  7. List of contributors
  8. About the editors
  9. Preface
  10. List of Illustrations
  11. List of Tables
  12. Chapter 1 : Hepatocellular carcinoma diagnosis
  13. Chapter 2 : Computational analysis of prognosis-related genes in liver cancer
  14. Chapter 3 : Computational approaches to identify biomarkers, enzymes, and pathways of hepatocellular carcinoma
  15. Chapter 4 : Ribonucleic acid sequence analysis in deciphering hepatocellular carcinoma
  16. Chapter 5 : Hepatocarcinogenesis and the role of next-generation sequencing in liver cancer
  17. Chapter 6 : Liver cancer: the tumor microenvironment and associated pathways
  18. Chapter 7 : Metabolic pathway-based target therapy to hepatocellular carcinoma: a computational approach
  19. Chapter 8 : Targeting ion channels in hepatic cancer
  20. Chapter 9 : Tyrosine kinases: their role in hepatocellular carcinoma
  21. Chapter 10 : Role of transcription factors in hepatocellular carcinoma
  22. Chapter 11 : Modulatory act of diverse transcriptional factors in liver carcinoma
  23. Chapter 12 : Association of specificity protein 1 with hepatocellular carcinoma
  24. Chapter 13 : Promising biomarkers for liver cancer
  25. Chapter 14 : Molecular signaling and its role in drug resistance in hepatocellular carcinomas
  26. Chapter 15 : Multidrug resistance, a major obstacle in hepatocellular carcinoma treatment: challenges and future perspectives
  27. Chapter 16 : Proliferative signaling pathways in hepatocellular carcinoma
  28. Chapter 17 : Targeting angiogenesis in hepatocellular carcinoma
  29. Chapter 18 : Conventional and novel biomarkers for the diagnosis and prognosis of liver cancer
  30. Chapter 19 : Updates on the staging and treatment of hepatocellular carcinoma
  31. Chapter 20 : ROS-mediated pathways: potential role in hepatocellular carcinoma biology and therapy
  32. Chapter 21 : Dysregulated cell-signaling pathways in hepatocellular carcinoma: causes and therapeutic options
  33. Chapter 22 : LKB1/STK11-mediated signal transduction in hepatocellular carcinoma
  34. Index
  35. A